Melanoma Clinical Trials
Melanoma clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for melanoma. Corterve aggregates actively recruiting Melanoma studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Melanoma studies
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.NCT05355701PHASE1PfizerFayetteville, Arkansas
- Sitagliptin With Pembro in RCC and MelanomaNCT07634380PHASE1Fernando Maciel BarbosaIowa City, Iowa
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)NCT04198766PHASE1, PHASE2Inhibrx Biosciences, IncDuarte, California
- Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic CancerNCT05267626PHASE1, PHASE2Aulos Bioscience, Inc.Miami, Florida
- A Study of Therapeutic Drug Monitoring-Based Atezolizumab DosingNCT06066138PHASE1National Cancer Institute (NCI)Bethesda, Maryland
- Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid TumorsNCT07628634EARLY_PHASE1University of California, IrvineOrange, California
- Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin CancerNCT05896839PHASE1, PHASE2National Cancer Institute (NCI)La Jolla, California
- A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsNCT05538130PHASE1PfizerBirmingham, Alabama
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasNCT07285044PHASE2Mayo ClinicJacksonville, Florida
- A Phase 1 of CTX-8371 in Patients With Advanced MalignanciesNCT06150664PHASE1Compass TherapeuticsMargate, Florida
- MySmartSkin Online Skin Self-exam Intervention for Melanoma SurvivorsNCT05373823NARutgers, The State University of New JerseyNew Brunswick, New Jersey
- BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyNCT05136196PHASE2National Cancer Institute (NCI)Phoenix, Arizona
Melanoma trials by state
Melanoma trials by metro
Frequently asked questions
- How do I find recruiting Melanoma clinical trials?
- Corterve aggregates actively recruiting Melanoma studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Melanoma clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Melanoma clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.